Herpes Simplex Encephalitis: Lack of Clinical Benefit of Long-term Valacyclovir Therapy
John W. Gnann(Birmingham VA Medical Center), Richard J. Whitley(University of Alabama at Birmingham), Daniel R. Hinthorn(University of Kansas Medical Center), Paul Griffiths(The Royal Free Hospital), Elisabeth Aurelius(Karolinska University Hospital), Silvia E. Schliamser(Skåne University Hospital), Daniel F. Hanley(Johns Hopkins University), John Hart, Ilet Dale(University of Alabama at Birmingham), Penelope Jester(University of Alabama at Birmingham), Alan C. Jackson(Queen's University), Clas Ahlm(Umeå University), Marie Studahl(University of Gothenburg), Salvador Cruz‐Flores(Texas Tech University), Birgit Sköldenberg(Karolinska University Hospital), B Eriksson(Uppsala University), Fred Y. Aoki, Lil Miedzinski(Alberta Hospital Edmonton), Allen J. Aksamit, Gretchen A. Cloud(University of Alabama at Birmingham), Diane Hanfelt-Goade(University of New Mexico)
Cited by 103
Related Papers
Recommendations for the Management of Herpes Zoster
|Clinical Infectious Diseases|2006|842
Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis
|Annals of Neurology|2018|758
Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy
|JAMA Neurology|2016|550
Glial fibrillary acidic protein immunoglobulin <scp>G</scp> as biomarker of autoimmune astrocytopathy: Analysis of 102 patients
|Annals of Neurology|2017|542
Steroid-Responsive Encephalopathy Associated With Autoimmune Thyroiditis
|Archives of Neurology|2006|527